AstraZeneca-Oxford vaccine should be effective for new Covid-19 variant: CEO Pascal Soriot

The AstraZeneca-Oxford Covid-19 vaccine approved by Britain on Wednesday should be effective against a rapidly spreading new variant of the virus, AstraZeneca's Chief Executive Pascal Soriot said.

"Our belief at this point is that this vaccine should be effective against the variant," he told BBC radio.